Chemistry of Torasemide. Molecular and Crystal Structure of New Polymorph N by Aleksandar Danilovski et al.
ISSN-0011-1643
CCA-2718 Original Scientific Paper
Chemistry of Torasemide.
Molecular and Crystal Structure
of New Polymorph N
Aleksandar Danilovski,* Darko Fili}, Marina Ore{i}, and Miljenko Dumi}
PLIVA d. d., Research and Development,
Prilaz baruna Filipovi}a 25, HR-10000 Zagreb, Croatia
Received July 14, 2000; revised October 27, 2000; accepted October 31, 2000
It is known from literature that torasemide, generic name for N1-
isopropyl-N3-4-(3-methylphenylamino)-3-pyridylsulphonylurea, can
have two polymorphic forms, denoted as T-I and T-II. A novel,
third polymorph N of torasemide, T-N has been discovered and
fully characterised. It crystallises in the centrosymmetric monocli-
nic space group P21/c with two crystallographically independent mo-
lecules, which differ primarily in their different phenyl ring and
N1-isopropyl side chain orientations. Both independent molecules,
i.e. conformations, can adopt a zwitter-ionic structure. The new poly-
morph of torasemide is characterised by a considerably complex
three-dimensional hydrogen-bonding network that spans all over
the crystal unit cell. The crystal packing of T-N is rather crowded,
dense and compact. It is pointed out that the degree of crystal
structure diversity of the existing torasemide polymorphs is con-
siderably high, with different conformational properties of distinct
torasemide molecules in its asymmetric unit.
Key words: torasemide, pyridylsulphonylurea, polymorphism, X-ray
diffraction, conformation.
INTRODUCTION
Torasemide, generic name for N1-isopropyl-N3-4-(3-methylphenylami-
no)-3-pyridylsulphonylurea, and many of its derivatives represent a new class
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of loop diuretics capable of inhibiting the NaCl reabsorption in the thick as-
cending limb of Henle's loop. Their diuretic activity may be attributed to a
strong inhibition of the luminal side of the Na+, 2Cl–, K+ cotransporter rather
than to inhibition of the chloride channels in the basolateral membrane of
this nephron. These substances interact in their anionic form with the Na+,
2Cl–, K+ cotransporter at the chloride ion binding site. As a new clinical per-
spective, antihypertensive indications of torasemide have been found, utilis-
ing the reduction of arterial pressure due to an increase in the intracellular
cAMP and cGMP content. Therefore, torasemide may be considered as the
first-line treatment in the mild to moderate essential hypertension, as well.1–4
In comparison with furosemide, the generic name for 3-carboxy-6-chlo-
ro-4-(2-furylamino)-1-phenylsulphonamide, as the reference high ceiling di-
uretic, torasemide demonstrates some interesting advantages; its inhibitory
properties may be manifested in a dose-dependent way at much lower con-
centrations and in a longer duration of action, it has equipotent activity af-
ter i.v. and p.o. application with almost 100% bioavailability after oral ad-
ministration, and it has lower potassium excretion. These features may be
promising for the clinical use of torasemide.4
Structurally, torasemide and its derivatives belong to the group of 4-sub-
stituted (4-alkyl, 4-cycloalkyl and 4-aryl) amino-3-pyridylsulphonyl moieties,
ranging from common ureas to their bioisosters guanidines and thioureas
(Figure 1). Therefore, these compounds could have a wide range of substituents
on either the 4-amino or the sulphonylurea N1 nitrogen atoms, as well as on
3-pyridylsulphonyl cores. Most of them behave as reasonably active diuretics.
Fortunately, these compounds do not exhibit the hypoglycemic activity a
characteristic of many sulphonylureas.4 If the 4-anilino and its related
groups, as most predominant amino-3-pyridylsulphonyl core substituents,
are investigated, with regard to the substitution on the 4-arylamino moiety
itself, one substituent is superior to the other two, i.e. R3-substitution is
superior to R2 or R4-substitution.4
It is known from literature that torasemide can have two polymorphic
forms, described as CSD5 codes TORSEM6 (T-I) and TORSEM017 (T-II).
Therefore, on this occasion we would like to report the discovery of a new,
third polymorph N of torasemide, i.e. polymorph T-N. Polymorphism could
be defined as the existence of more than one crystalline form of the same
chemical substance. It is affected by the ability of a discrete molecule to
change its conformation and(or) to form different intermolecular and intra-
molecular interactions, particularly hydrogen bonds. This is reflected in dif-
ferent atom arrangements in the crystal lattices of different polymorphs.8,9
Additionally, the intention of this paper is to confirm unambiguously the
crystal structure uniqueness and existence of this new, third polymorph T-N
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of torasemide. Special attention is paid to indicating the crystal structure
diversity among the three existing polymorphs of torasemide, as well as to
point out the different conformational properties of distinct torasemide
molecules in its asymmetric unit.
EXPERIMENTAL
Chemistry
Torasemide was synthesised in accordance with the procedure described in DE
Pat. 2516025,10 while the new polymorph of torasemide T-N was prepared in accor-
dance with PCT/WO Pat. Appl. No. 0020395.11
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Figure 1. Possible chemical modifications on the 4-substituted amino-3-pyridylsul-
phonyl cores, with emphasis on structural differences between two commercial di-
uretics, torasemide (1) and furosemide (2).
X-Ray Structure Analysis
The single crystal of the new polymorph N of torasemide chosen for the X-ray
structure determination was a colourless prism with dimensions 0.60 0.45 0.36 mm3.
It was obtained by slow evaporation of methanol solution at a temperature of 4 °C.
The cell parameters and intensities were collected on a PHILIPS PW1100 auto-
matic four-circle diffractometer (Stoe/Cie upgrade) using graphite mono-chromatised
Mo-Ka radiation (l = 0.71069 Å), at room temperature. STADI4 programme12 was
used for the control of the diffractometer. Intensities were measured by the w-scan
technique. The measured intensity data were corrected for Lorentz and polarisation
effects (XRED programme),13 but not for absorption.
The molecular and crystal structure of the title compound was solved by direct
methods incorporated in the SHELXS-97 programme14 and refined on F2 with ani-
sotropic displacement parameters for all non-hydrogen atoms, by the SHELXL-97
programme.15 The pyridine hydrogen atoms were located in the difference Fourier
maps, while all other hydrogen atoms were let to ride on their carrier non-hydrogen
atoms, at calculated positions.
Drawings of molecular and crystal structures were prepared by the PLATON-
2000 programme,16 while crystal packings were prepared by the WebLab Viewer Pro
3.20 programme.17 PARST-96 programme18 was used to calculate the molecular ge-
ometries, i.e. hydrogen bonding, best planes, etc.
RESULTS AND DISCUSSION
Description of the Molecular and Crystal Structure
of the New Polymorph of Torasemide T-N
The new polymorph of torasemide T-N is crystallised in the centro-
symmetric monoclinic space group P21/c in the presence of two crystallo-
graphically independent molecules (T-NA and T-NB) per asymmetric unit.
A view of the only one independent molecule (T-NA) with the atomic numbe-
ring scheme is shown in Figure 2. The majority of relevant details concern-
ing the general crystal data and intensity collections are listed in Table I,
while selected geometric parameters, i.e. selected bond lengths, bond and
torsion angles are listed in Table II (data have been already deposited in
CCDC, as supplementary material).19
The overlap diagram (Figure 3) of two independent molecules of T-N
was prepared by fitting atoms of the 3-pyridosulphonamide moiety, i.e. by
matching atoms N1, C2, C3, C4, C5, C6, S31 and N34. The root mean
square difference (RMSD)20 between matched atoms of 0.106 Å indicates
uniqueness of these two independent molecules with their conformational
diversity, mainly in different phenyl ring and N1-isopropyl side chain orien-
tations.
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3-Pyridylsulphonylureas, guanidines and(or) thioureas are suitable for
achieving various resonance forms (see Figure 4). Depending on the specific
reaction conditions applied for their synthesis, they can exist in a simple
neutral or in more complex ionic forms, manifested as counter-ions or zwit-
ter-ions. Among the different possibilities, resonance forms (I) and (II) are
the most predominant ones and are attributed to neutral or counter-ionic,
and zwitter-ionic structures, respectively. Bond length analysis of T-N and
its comparison with standard bond length values for organic compounds, ac-
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TABLE I
Crystal data and structure refinement parameters for








a / Å 11.430(3)
b / Å 19.090(6)
c / Å 16.695(6)
b / ° 93.90(2)
V / Å3 3634(2)
Z 4  2
Dx / g cm–3 1.274
F(000) 1472
m (Mo-Ka) / mm–1 0.199






Used in refinement 6386




Goodness of fit, S 0.974
Drmax; Drmin / e Å–3 0.288; –0.251
a
I  2s(I).
cording to F. H. Allen et al.,21 suggests that both crystallographically inde-
pendent molecules adopt zwitter-ionic structure with the prevalent resonance
form (II). Even though bonds S31–O32, S31–O33 and C35–O36 have an ex-
plicit double bond character characteristic of the resonance form (II), a rela-
tive shortening of the S31–N34 single bond followed by the N34–C35 single
bond lengthening are noticed. Besides, the location of hydrogen atom, in the
difference Fourier map, in the vicinity of pyridine nitrogen atom, enabled
N1–H1 bond formation and led to the hypothesis of the presence of a pyri-
dinium cation moiety assigned to the resonance form (II). The pyridinium
cation is formed due to the deprotonation of sulphonamide nitrogen atom
yielding N34 nitrenium anion. As a consequence, the side chain is in an an-
ionic form, which favours interaction with the Na+, 2Cl–, K+ cotransporter at
the chloride ion binding site.22
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Figure 2. Molecular structure of one crystallographically independent molecule T-NA
of the new polymorph T-N of torasemide, showing the atomic numbering scheme.
Displacement ellipsoids are drawn at the 40% probability level, while hydrogen atoms
are drawn as spheres of arbitrary radii.
As another conformational discrepancy between the two crystallographi-
cally independent molecules T-NA and T-NB, a different relative orientation
of pyridine and phenyl rings is found. The best planes through these rings
could be defined as follows; atoms N1, C2, C3, C4, C5 and C6 outline the
best pyridine ring plane, while atoms C1', C2', C3', C4', C5' and C6' outline
the phenyl ring. The dihedral angles between these best planes are 80.3(2)°
and 62.8(3)° in molecules T-NA and T-NB, respectively.
The new polymorph of torasemide T-N is characterised by a considerably
complex three-dimensional hydrogen-bonding network. Figure 5 depicts all
possible hydrogen bonds between two independent molecules in the crystal
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TABLE II
Selected bond lengths, angles and torsion angles with their
standard uncertainties (s.u.) for both independent molecules
of the new polymorph T-N of torasemide
Parameter T-NA T-NB
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Figure 3. Overlap diagram of two crystallographically independent molecules of the
new polymorph T-N of torasemide, in orthogonal projection. Molecule T-NA is de-























































Figure 4. Plausible resonance forms of 3-pyridylsulphonyl moiety (X = O, S, N), i.e.
3-pyridylsulphonylureas, guanidines and/or thioureas. The most abundant forms (I)
and (II) are highlighted as grey boxes.
unit cell. According to the achieved patterns, they could be classified in three
major groups, i.e. the first group (i) is made up of intramolecular hydrogen
bonds only, the second (ii) of intermolecular hydrogen bonds that interlink
independent molecules of the same origin (e.g. A–A or B–B), and the third
(iii) of intermolecular bonds that bring together different independent mole-
cules (e.g. A–B). Hydrogen bonds are designated according to the graph-set
notation introduced by Bernstein et al.23 (Table III).
The core building elements of this complex hydrogen-bonding network
are dimeric A–A and B–B units that are formed through N1A(B)'–H1A(B)'
N34A(B) and N37A(B)–H37A(B)O32A(33B) hydrogen bonds, resulting in
two nearly perpendicular binary ring patterns, i.e. 8- and 12-membered
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Figure 5. Hydrogen-bonding network of the new polymorph T-N of torasemide. Crystal-
lographically independent molecule T-NA is depicted in cyan, while molecule T-NB
in yellow colour, with the underlying symmetry codes in brackets. Hydrogen bonds
are shown as dashed lines.



























































































































































































































































































































































































































































































































































































































































































































































































































































































































2 8( ) and R2
4 12( ). Through pyridine N1A(B) and aromatic C6A(2B), as
donor atoms, and via sulphonic O33A(32B) and carbonyl O36A(B), as accep-
tor atoms, dimeric units A–A and B–B are linked with each other, outlining
various binary patterns ranging from chains, C2
2 12( ), C2
2 14( ) and C3
2 14( ) to
rings, R1
3 7( ), R2
1 5( ) and R2
3 9( ). By combining these patterns, three distinct 4-
membered infinite chains with repetition model A–A–B–B–A, A–B–B–A–A
and A–B–A–B–A throughout directions 1 1 0, –1 –1 0 and 0 0 –1, respec-
tively, are created, giving a well-defined three-dimensional network. Two
12-membered and eight 14-membered circuits spanning all over the unit
cell are an additional feature of this unique crystal packing (Figure 6).
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Figure 6. Packing diagram representing 121 crystal planes of the new polymorph
T-N of torasemide viewed down the c 001 axes. Crystallographically independent
molecule T-NA is depicted in cyan as a »space-filling« model, while molecule T-NB in
yellow as a »ball and stick« model.
Search for and analysis of solvent accessible voids in the crystal packing
revealed a potential solvent accessible volume of approximately 150 Å3
(around 4% of the total unit cell volume). Having in mind that a simple wa-
ter molecule has a volume of about 40 Å3 and that the new polymorph T-N
has 8 discrete molecules (4  2) in its unit cell, it may be concluded that not
even a monohydrate (needed voids volume of cca. 320 Å3) is possible. There-
fore, the crystal packing of the new polymorph T-N is solvent free, dense
and compact, as can be clearly seen in Figure 6. In addition, by comparing
the crystal packings of all three torasemide polymorphs, it can be seen that
polymorph T-I is the most condensed one (Dx = 1.33 g cm
–3), with no sub-
stantial solvent accessible voids, polymorph T-II should be considered as the
least dense one (Dx = 1.18 g cm
–3) with cca. 550 Å3 of solvent accessible volume
(around 15% of the total unit cell volume), while the new polymorph T-N
represents an intermediate case (Dx = 1.274 g cm
–3).
Three Polymorphs of Torasemide. Similarity vs. Diversity
Up to now, it was known that torasemide can exist in two polymorphic
forms, T-I and T-II. Comparison of their unit cell parameters with the here
reported new polymorph T-N have unquestionably confirmed the novelty of
our polymorph (Table IV). From Table IV one can conclude that all three
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TABLE IV
Comparison of unit cell parameters for all known polymorphs of torasemide
Parameter T-Ia T-IIb T-N
Crystal system Monoclinic Monoclinic Monoclinic
Space group P21/c P2/n P21/c
Unit cell parameters:
a / Å 13.308 20.446(4) 11.430(3)
b / Å 8.223 11.615(3) 19.090(6)
c / Å 31.970 16.877(4) 16.695(6)
b / ° 107.01 108.9 93.90(2)
V / Å3 3345.5 3791.9 3634(2)
Z 4  2 4  2 4  2
Dx / g cm–3 1.33 1.18 1.274
RF 0.074 0.089 0.059
a CSD code: TORSEM.22 The unit cell parameters could be reduced to another monoclinic unit
cell: a = 13.308 Å, b = 8.223 Å, c = 30.826 Å and  = 97.37°.
b CSD code: TORSEM01.23
polymorphs belong to the same monoclinic crystal system but with con-
siderably different and therefore unique unit cell parameters. All three poly-
morphs have two crystallographically independent molecules in their asym-
metric unit, giving a total of six possible conformations.
The overlap diagram (Figure 7) of these six independent molecules is
made analogous to Figure 3, i.e. by fitting atoms of the 3-pyridosulphon-
amide moiety. As with two independent molecules of the new T-N poly-
morph, it is apparent from Figure 7 that all six conformations are diversi-
fied by different phenyl ring and N1-isopropyl side chain orientations.
Conformational properties of these six 3-pyridylsulphonylurea moieties
correspond in general to case II of the conjugation in sulphone j(1) = –90°;
j(2) = 90°.24 In order to understand this historical pyridylsulphonylurea
classification, we need to define the following conventional torsion angles
designed as j(1), j(2), j(3) and j(4), representing C4–C3–S31–N34,
C3–S31–N34–C35, S31–N34–C35–N37 and N34–C35–N37–C38, respectively.
According to that, Dupont et al.25 proposed the following description of the
pyridylsulphonylureas by three distinct conformational classes, a j(1) = –90°;
j(2) = 90°; j(3) = 180°; j(4) = 180°, b j(1) = –90°; j(2) = –90°; j(3) = 180°;
j(4) = 0° and g j(1) = –90°; j(2) = –90°; j(3) = 180°; j(4) = 180°. As already
mentioned, torasemide crystallises in three different unit cells while adopt-
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Figure 7. Overlap diagrams of all six crystallographically independent molecules found
in three torasemide polymorphs, in orthogonal projections. Polymorph T-I is depicted
in blue (molecule T-IA) and in red (molecule T-IB), T-II in green (molecule T-IIA) and
in magenta (molecule T-IIB), while polymorph T-N in cyan (molecule T-NA) and in yellow
colour (molecule T-NB). Hydrogen atoms are omitted for clarity.
ing all three possible conformational classes (Table V). Consequently, both
independent molecules, i.e. conformations of polymorphs T-II and T-N, be-
long to the same conformational class g, while T-I adopts both a and b
classes. Because this conformational classification is based on a rather high
torsion angle step size, e.g. of 90° and 180°, used for rounding up the torsion
angle values, it would be more appropriate and reliable to cluster these con-
formations in accordance with their root mean square difference (RMSD) be-
tween the matched 3-pyridylsulphonyl core atoms (Table VI). As a RMSD
cluster criterion, the fairly rigorous cut-off value of 0.100 Å is applied,
meaning that conformations with RMSD  0.100 Å belong to the same clus-
ter, and vice versa, the ones with RMSD > 0.100 Å outlining different
conformational clusters. Clustering analysis confirmed the results of the
previously mentioned conformational classification, but with a significantly
higher impact on fine conformational details. Thus, for example, one can see
that conformations T-IIA, T-IIB and T-NA are much more closely related to
each other than to the T-NB conformation, which just barely belong to the
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TABLE V
Conformational classification of six possible crystallographically independent
molecules of torasemide, according to Dupont et al.25
T-I T-II T-N
T-IA T-IB T-IIA T-IIB T-NA T-NB
Torsion angle / °
j(1)expa 105.7 77.5 51.3 47.8 48.9 57.5
j(2)exp –65.5 71.7 62.2 60.7 69.0 65.3
j(3)exp –179.7 172.0 –163.0 –162.7 –166.7 –159.7
j(4)exp –177.3 –14.4 –178.2 170.1 –178.3 –177.7
j(1)classb 90 90 90 90 90 90
j(2)class –90 90 90 90 90 90
j(3)class 180 180 180 180 180 180
j(4)class 180 0 180 180 180 180
Conformation class
a b g g g g
a All torsion angles are enlisted with the same relative orientation of the sulphonylurea moi-
ety to the T-I target molecule. Therefore, the torsion angle values for T-N are inverted, as
compared to the ones given in Table II.
b Torsion angle values are rounded up to the closest number with the step size of 90° for j(1)
and j(2), while with the step size of 180° for j(3) and j(4), respectively.
same cluster. This approach becomes more advantageous when trying to
compare all the crystallised 4-substituted 3-pyridylsulphonyl analogues,
such as various ureas, guanidines and thioureas, with which the old classifi-
cation protocol would have serious problems due to its already revealed bot-
tlenecks.26
Analysis of bond lengths for all six crystallographically independent mo-
lecules, (Table VII), reveals the expected predominance of the zwitter-ionic
resonance form (II). The only exception is the T-IA molecule that possesses
a neutral resonance form (I). Nevertheless, it should be stressed that due to
the rather poor quality of experimental data (data from 1978) and overall
refinement accuracy for known polymorphs T-I (RF = 0.074) and T-II
(RF = 0.089), their published hydrogen positions are somewhat unreliable
and could influence the relative distribution of the relevant resonance forms.
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TABLE VI
Conformational clustering of all six possible crystallographically independent
molecules of torasemide, applying the RMSD cut-off value of 0.100 Å
RMSDa / Å
T-IA T-IB T-IIA T-IIB T-NA T-NB
T-IA
(a conform.)
0.206 0.391 0.415 0.428 0.340
T-IB
(b conform.)












a Conformations belonging to the same cluster according to the applied RMSD cut-off criteria
are highlighted as bold-underlined.
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Kemija torasemida. Molekulska i kristalna struktura
novog polimorfa N
Aleksandar Danilovski, Darko Fili}, Marina Ore{i} i Miljenko Dumi}
Iz literature je poznato kako se torasemid, generi~ko ime za N1-izopropil-N3-
4-(3-metilfenilamino)-3-piridilsulfonilureu, mo`e pojavljivati u dva polimorfna obli-
ka T-I i T-II. Me|utim, otkriven je, potpuno okarakteriziran i nedvojbeno dokazan
novi polimorf torasemida, odnosno T-N. Novi polimorf T-N kristalizira u centrosime-
tri~noj monoklinskoj prostornoj grupi P21/c s dvije kristalografski neovisne molekule
koje se me|usobno razlikuju u prostornim rasporedima svojih fenilnih prstenova i
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N
1-izopropilnih pobo~nih lanaca. Obje kristalografski neovisne molekule nalaze se u
obliku dvojnog iona. Osnovna zna~ajka novog polimorfa torasemida jest slo`ena tro-
dimenzijska mre`a vodikovih veza koja se prote`e kroz cijelu kristalnu re{etku
rezultiraju}i prili~no zgusnutim i kompaktnim pakiranjem molekula polimorfa T-N
u njegovoj kristalnoj re{etki. U kona~nici, istaknut je visok stupanj strukturne razno-
likosti, odnosno unikatnosti, kristalnih struktura sva tri polimorfa torasemida, kao i raz-
li~itost konformacijskih zna~ajki njihovih molekula u asimetri~noj jedinici.
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